Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Fluidigm Corporation stock

Own Fluidigm Corporation stock in just a few minutes.

Fluidigm Corporation is a diagnostics & research business based in the US. Fluidigm Corporation shares (FLDM) are listed on the NASDAQ and all prices are listed in US Dollars. Fluidigm Corporation employs 627 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Fluidigm Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FLDM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Fluidigm Corporation share price

Use our graph to track the performance of FLDM stocks over time.

Fluidigm Corporation shares at a glance

Information last updated 2021-04-30.
52-week range$2.76 - $10.10
50-day moving average $4.59
200-day moving average $5.74
Wall St. target price$10.33
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.32

Buy Fluidigm Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Fluidigm Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Fluidigm Corporation under- or over-valued?

Valuing Fluidigm Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fluidigm Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Fluidigm Corporation's PEG ratio

Fluidigm Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fluidigm Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Fluidigm Corporation financials

Revenue TTM $138.1 million
Gross profit TTM $46.9 million
Return on assets TTM -10.82%
Return on equity TTM -36.23%
Profit margin -38.38%
Book value $1.87
Market capitalisation $377.1 million

TTM: trailing 12 months

Shorting Fluidigm Corporation shares

There are currently 8.0 million Fluidigm Corporation shares held short by investors – that's known as Fluidigm Corporation's "short interest". This figure is 12.9% down from 9.2 million last month.

There are a few different ways that this level of interest in shorting Fluidigm Corporation shares can be evaluated.

Fluidigm Corporation's "short interest ratio" (SIR)

Fluidigm Corporation's "short interest ratio" (SIR) is the quantity of Fluidigm Corporation shares currently shorted divided by the average quantity of Fluidigm Corporation shares traded daily (recently around 1.1 million). Fluidigm Corporation's SIR currently stands at 7.43. In other words for every 100,000 Fluidigm Corporation shares traded daily on the market, roughly 7430 shares are currently held short.

However Fluidigm Corporation's short interest can also be evaluated against the total number of Fluidigm Corporation shares, or, against the total number of tradable Fluidigm Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fluidigm Corporation's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Fluidigm Corporation shares in existence, roughly 110 shares are currently held short) or 0.1083% of the tradable shares (for every 100,000 tradable Fluidigm Corporation shares, roughly 108 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Fluidigm Corporation.

Find out more about how you can short Fluidigm Corporation stock.

Fluidigm Corporation share dividends

We're not expecting Fluidigm Corporation to pay a dividend over the next 12 months.

Fluidigm Corporation share price volatility

Over the last 12 months, Fluidigm Corporation's shares have ranged in value from as little as $2.76 up to $10.1. A popular way to gauge a stock's volatility is its "beta".

FLDM.US volatility(beta: 1.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fluidigm Corporation's is 1.5626. This would suggest that Fluidigm Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Fluidigm Corporation overview

Fluidigm Corporation creates, manufactures, and markets technologies and life sciences tools worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, Hyperion tissue imager, and flow conductor; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. , as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. Fluidigm Corporation sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site